keyword
MENU ▼
Read by QxMD icon Read
search

polymyositis guidelines

keyword
https://www.readbyqxmd.com/read/27824785/commentary-on-3-unusual-cases-involving-electroconvulsive-therapy
#1
David A Kahn
Well-established practice guidelines and a solid body of evidence underpin the safe and effective use of electroconvulsive therapy (ECT), primarily in mood disorders. In this issue of the journal, 3 case reports deal with situations that fall outside of the usual guidelines: treatment resistance to ECT overcome by combined use with antidepressant medication; use of ECT in the presence of polymyositis; and use of ECT for an unusually severe case of neuroleptic malignant syndrome, assisted by consultation from an online expert resource...
November 2016: Journal of Psychiatric Practice
https://www.readbyqxmd.com/read/27514198/-rheumatology-progress-in-diagnosis-and-treatments-topics-iv-collagen-diseases-except-for-rheumatoid-arthritis-and-hot-topics-4-polymyositis-and-dermatomyositis
#2
REVIEW
Ran Nakashima
No abstract text is available yet for this article.
October 10, 2014: Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine
https://www.readbyqxmd.com/read/27390939/left-ventricular-diastolic-dysfunction-and-increased-left-ventricular-mass-index-related-to-pulmonary-hypertension-in-patients-with-systemic-autoimmune-disease-without-pericardial-effusion
#3
Atsushi Sugiura, Nobusada Funabashi, Koya Ozawa, Yoshio Kobayashi
PURPOSE: We investigated the relationship of left ventricular (LV) diastolic dysfunction and LV mass index (LVMI) against pulmonary hypertension (PH) in systemic autoimmune disease (SAD). METHODS: A total of 84 SAD patients (68 females; 53±17years; systemic lupus erythematosus, 27%; scleroderma, 17%; vasculitis, 16%; mixed connective tissue disease, 13% and polymyositis/dermatomyositis complex, 10%) without significant pericardial effusion (PE) on TTE (Vivid E9, GE) were analyzed...
October 1, 2016: International Journal of Cardiology
https://www.readbyqxmd.com/read/26299472/the-evidence-for-immunotherapy-in-dermatomyositis-and-polymyositis-a-systematic-review
#4
REVIEW
Erin Vermaak, Sarah L Tansley, Neil J McHugh
Dermatomyositis and polymyositis are rare chronic inflammatory disorders with significant associated morbidity and mortality despite treatment. High-dose corticosteroids in addition to other interventions such as immunosuppressants, immunomodulators, and more recently, biologics are commonly used in clinical practice; however, there are no clear guidelines directing their use. Our objective was to systematically review the evidence for immunotherapy in the treatment of dermatomyositis and polymyositis. Relevant studies were identified through Embase and PubMed database searches...
December 2015: Clinical Rheumatology
https://www.readbyqxmd.com/read/23756459/connective-tissue-ulcers
#5
Ganary Dabiri, Vincent Falanga
Connective tissue disorders (CTD), which are often also termed collagen vascular diseases, include a number of related inflammatory conditions. Some of these diseases include rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis (scleroderma), localized scleroderma (morphea variants localized to the skin), Sjogren's syndrome, dermatomyositis, polymyositis, and mixed connective tissue disease. In addition to the systemic manifestations of these diseases, there are a number of cutaneous features that make these conditions recognizable on physical exam...
November 2013: Journal of Tissue Viability
https://www.readbyqxmd.com/read/23540178/guidelines-for-the-use-of-intravenous-immunoglobulin-in-the-treatment-of-neurologic-diseases
#6
Vanja Bascić-Kes, Petar Kes, Iris Zavoreo, Marijana Lisak, Lucija Zadro, Lejla Corić, Vida Demarin
The use of intravenous immunoglobulin (IVIg) in the management of patients with neuroimmune disorders has shown a progressive trend over the last few years. Despite the wide use of IVIg, consensus on its optimal use is deficient. The European Federation of Neurological Societies (EFNS) guidance regulations offer consensus recommendations for optimal use of IVIg. The effectiveness of IVIg has been proven in Guillain-Barré syndrome (level A), chronic inflammatory demyelinating polyradiculoneuropathy (level A), multifocal mononeuropathy (level A), acute exacerbations of myasthenia gravis and short-term treatment of severe myasthenia gravis (level A)...
December 2012: Acta Clinica Croatica
https://www.readbyqxmd.com/read/23274022/idiopathic-inflammatory-myopathies-current-trends-in-pathogenesis-clinical-features-and-up-to-date-treatment-recommendations
#7
REVIEW
Floranne C Ernste, Ann M Reed
Recently, there have been important advances in the understanding of the pathophysiologic features, assessment, and management of patients with a newly diagnosed idiopathic inflammatory myopathy (IIM). Myositis-specific autoantibodies have been identified to define patient subgroups and offer prognostic implications. Similarly, proinflammatory cytokines, such as interleukin 6 and type 1 interferon-dependent genes, may serve as potential biomarkers of disease activity in adult and juvenile patients with dermatomyositis (DM)...
January 2013: Mayo Clinic Proceedings
https://www.readbyqxmd.com/read/23269233/correlation-of-clinicoserologic-and-pathologic-classifications-of-inflammatory-myopathies-study-of-178-cases-and-guidelines-for-diagnosis
#8
Carla Fernandez, Nathalie Bardin, André Maues De Paula, Emmanuelle Salort-Campana, Audrey Benyamine, Jérôme Franques, Nicolas Schleinitz, Pierre-Jean Weiller, Jean Pouget, Jean-François Pellissier, Dominique Figarella-Branger
The idiopathic inflammatory myopathies (IIM) are acquired muscle diseases characterized by muscle weakness and inflammation on muscle biopsy. Clinicoserologic classifications do not take muscle histology into account to distinguish the subsets of IIM. Our objective was to determine the pathologic features of each serologic subset of IIM and to correlate muscle biopsy results with the clinicoserologic classification defined by Troyanov et al, and with the final diagnoses. We retrospectively studied a cohort of 178 patients with clinicopathologic features suggestive of IIM with the exclusion of inclusion body myositis...
January 2013: Medicine (Baltimore)
https://www.readbyqxmd.com/read/22454268/evidence-based-guideline-intravenous-immunoglobulin-in-the-treatment-of-neuromuscular-disorders-report-of-the-therapeutics-and-technology-assessment-subcommittee-of-the-american-academy-of-neurology
#9
REVIEW
H S Patwa, V Chaudhry, H Katzberg, A D Rae-Grant, Y T So
OBJECTIVE: To assess the evidence for the efficacy of IV immunoglobulin (IVIg) to treat neuromuscular disorders. METHODS: The MEDLINE, Web of Science, and EMBASE databases were searched (1966-2009). Selected articles were rated according to the American Academy of Neurology's therapeutic classification of evidence scheme; recommendations were based on the evidence level. RESULTS AND RECOMMENDATIONS: IVIg is as efficacious as plasmapheresis and should be offered for treating Guillain-Barré syndrome (GBS) in adults (Level A)...
March 27, 2012: Neurology
https://www.readbyqxmd.com/read/22015567/pulmonary-arterial-hypertension-in-connective-tissue-diseases
#10
REVIEW
Shunji Yoshida
Pulmonary hypertension (PH) was found to be the primary cause of death in mixed connective tissue disease (MCTD). This led to investigation of the prevalence of PH in other connective tissue diseases (CTD). In 1998, the Ministry of Health and Welfare's MCTD Research Committee revealed complication of PH diagnosed by physicians in 5.02% MCTD patients, 0.90% systemic lupus erythematosus patients, 2.64% systemic sclerosis patients, and 0.56% polymyositis/dermatomyositis patients. These results have been supported by a similar survey performed in North America...
December 2011: Allergology International: Official Journal of the Japanese Society of Allergology
https://www.readbyqxmd.com/read/20390114/-how-to-prescribe-physical-exercise-in-rheumatology
#11
REVIEW
S Maddali Bongi, A Del Rosso
Physical exercise, aiming to improve range of movement, muscle strength and physical well being, lately substituted the immobilization previously prescribed in rheumatic diseases. International guidelines, recommendations of Scientific Societies, and structured reviews regard physical exercise as of pivotal importance in treating rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, fibromyalgia syndrome, osteoporosis, and to be considered in connective tissue diseases. Therapeutic exercise should: aim to improve firstly local symptoms and then general health; respect the pain threshold; be a part of a treatment including pharmacological therapies and other rehabilitation techniques, be administered by skilled physiotherapist under the guide of a rheumatologist, be different according to different diseases, disease phases and patient expectations...
January 2010: Reumatismo
https://www.readbyqxmd.com/read/20146942/vitamin-d-and-autoimmune-rheumatologic-disorders
#12
REVIEW
Christina F Pelajo, Jorge M Lopez-Benitez, Laurie C Miller
Vitamin D levels depend on many variables, including sun exposure, age, ethnicity, body mass index, use of medications and supplements. A much higher oral vitamin D intake than the current guidelines is necessary to maintain adequate circulating 25(OH)D levels in the absence of UVB radiation of the skin. In addition to the traditional known metabolic activities, vitamin D has been shown to modulate the immune system, and its deficiency has been linked to the development of several autoimmune disorders including type 1 diabetes and multiple sclerosis...
May 2010: Autoimmunity Reviews
https://www.readbyqxmd.com/read/19966877/intravenous-immunoglobulin-therapy-for-neurological-disorders
#13
Catriona Harkins, Graeme Hammond-Tooke, James Faed
AIM: To determine the extent to which the use of intravenous human immunoglobulin for neurological conditions complied with the guidelines of the Australian Health Minister's Advisory Council. METHODS: Patients treated with intravenous immunoglobulin in Otago over a 5.5-year period were identified from the records of the New Zealand Blood Service and the hospital files were reviewed. RESULTS: 200 patients received immunoglobulin therapy, of whom 57 had neurological conditions: myasthenia gravis, (15...
October 30, 2009: New Zealand Medical Journal
https://www.readbyqxmd.com/read/19444116/rheumatic-manifestations-associated-with-hiv-in-the-highly-active-antiretroviral-therapy-era
#14
REVIEW
Binh Y Nguyen, John D Reveille
PURPOSE OF REVIEW: To evaluate the rheumatic manifestations associated with HIV infection in the highly active antiretroviral therapy (HAART) era. RECENT FINDINGS: The overall prevalence of rheumatic manifestations in HIV population is approximately 9% with various clinical features. Anti-TNF agents do not appear to adversely affect the CD4 cell counts or viral load if the HIV infection is well controlled prior to initiation of therapy. SUMMARY: In the HAART era, HIV-infected individuals can be affected by various rheumatic syndromes including arthritis, spondyloarthritis, DILS, vasculitides, connective tissue disease, myopathies, and musculoskeletal diseases...
July 2009: Current Opinion in Rheumatology
https://www.readbyqxmd.com/read/19019306/idiopathic-inflammatory-myopathies-current-and-future-therapeutic-options
#15
REVIEW
Heinz Wiendl
Idiopathic inflammatory myopathies (notably polymyositis and dermatomyositis) are relatively uncommon diseases with a heterogeneous clinical presentation. Only a few randomized, double-blind, placebo-controlled trials have been performed, measures to assess outcome and response to treatment have to be validated. Initial treatment options of first choice are corticosteroids, although rarely tested in randomized, controlled trials. Unfortunately, not all patients respond to them and many develop undesirable side effects...
October 2008: Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutics
https://www.readbyqxmd.com/read/18974552/inflammatory-muscle-diseases
#16
REVIEW
F L Mastaglia
The three major immune-mediated inflammatory myopathies, dermatomyositis (DM), polymyositis (PM) and inclusion body myositis (IBM), each have their own distinctive clinical features, underlying pathogenetic mechanisms and patterns of muscle gene expression. In DM a complement-dependent humoral process thought to be initiated by antibodies to endothelial cells results in a microangiopathy with secondary ischemic changes in muscles. On the other hand, in PM and IBM there is a T-cell response with invasion of muscle fibers by CD8+ lymphocytes and perforin-mediated cytotoxic necrosis...
July 2008: Neurology India
https://www.readbyqxmd.com/read/18796075/efns-guidelines-for-the-use-of-intravenous-immunoglobulin-in-treatment-of-neurological-diseases-efns-task-force-on-the-use-of-intravenous-immunoglobulin-in-treatment-of-neurological-diseases
#17
I Elovaara, S Apostolski, P van Doorn, N E Gilhus, A Hietaharju, J Honkaniemi, I N van Schaik, N Scolding, P Soelberg Sørensen, B Udd
Despite high-dose intravenous immunoglobulin (IVIG) is widely used in treatment of a number of immune-mediated neurological diseases, the consensus on its optimal use is insufficient. To define the evidence-based optimal use of IVIG in neurology, the recent papers of high relevance were reviewed and consensus recommendations are given according to EFNS guidance regulations. The efficacy of IVIG has been proven in Guillain-Barré syndrome (level A), chronic inflammatory demyelinating polyradiculoneuropathy (level A), multifocal mononeuropathy (level A), acute exacerbations of myasthenia gravis (MG) and short-term treatment of severe MG (level A recommendation), and some paraneoplastic neuropathies (level B)...
September 2008: European Journal of Neurology: the Official Journal of the European Federation of Neurological Societies
https://www.readbyqxmd.com/read/18366757/idiopathic-pulmonary-fibrosis
#18
REVIEW
Eric B Meltzer, Paul W Noble
Idiopathic pulmonary fibrosis (IPF) is a non-neoplastic pulmonary disease that is characterized by the formation of scar tissue within the lungs in the absence of any known provocation. IPF is a rare disease which affects approximately 5 million persons worldwide. The prevalence is estimated to be slightly greater in men (20.2/100,000) than in women (13.2/100,000). The mean age at presentation is 66 years. IPF initially manifests with symptoms of exercise-induced breathless and dry coughing. Auscultation of the lungs reveals early inspiratory crackles, predominantly located in the lower posterior lung zones upon physical exam...
2008: Orphanet Journal of Rare Diseases
https://www.readbyqxmd.com/read/18021522/disease-specific-quality-indicators-outcome-measures-and-guidelines-in-polymyositis-and-dermatomyositis
#19
H Alexanderson, I E Lundberg
Polymyositis and dermatomyositis are chronic inflammatory muscle disorders with frequent involvement of other organs hence outcome measures should include these different aspects of disease. Muscle strength and muscle endurance are the most specific clinical features that should be assessed during treatment and longitudinal follow-up. Extramuscular involvement should also be assessed. An international, interdisciplinary network, the International Myositis Assessment Clinical Study Group (IMACS) has proposed a core set of outcome measures to assess three dimensions of myositis disease; disease activity (MYOACT), disease damage (MYODAM) and health related quality of life (SF-36) to be used in clinical trials...
November 2007: Clinical and Experimental Rheumatology
https://www.readbyqxmd.com/read/17397768/guidelines-on-the-use-of-intravenous-immune-globulin-for-neurologic-conditions
#20
Tom Feasby, Brenda Banwell, Timothy Benstead, Vera Bril, Melissa Brouwers, Mark Freedman, Angelika Hahn, Heather Hume, John Freedman, David Pi, Louis Wadsworth
Canada's per capita use of intravenous immune globulin (IVIG) grew by approximately 115% between 1998 and 2006, making Canada one of the world's highest per capita users of IVIG. It is believed that most of this growth is attributable to off-label usage. To help ensure IVIG use is in keeping with an evidence-based approach to the practice of medicine, the National Advisory Committee on Blood and Blood Products (NAC) and Canadian Blood Services convened a panel of national experts to develop an evidence-based practice guideline on the use of IVIG for neurologic conditions...
April 2007: Transfusion Medicine Reviews
keyword
keyword
119705
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"